Nutritional differences in neurologically impaired children

Alura Riley1, Christina Vadeboncoeur

  • 1Queen's University, School of Medicine, Kingston; ; Children's Hospital of Eastern Ontario;

Insights

Nutritional intake recommendations were not met by neurologically impaired children. Despite low weight-for-age percentiles, body fat measures suggest adequate intake, indicating standard growth charts may be unsuitable.

Area of Science:

  • Pediatric Nutrition
  • Neurology
  • Growth Assessment

Background:

  • Children with moderate to severe neurological impairments often face nutritional challenges.
  • Assessing adequate nutritional intake in this population requires careful consideration of growth parameters.

Purpose of the Study:

  • To evaluate if recommended nutritional intake aligns with growth expectations in neurologically impaired children.
  • To determine the suitability of current growth parameters for this specific pediatric group.

Main Methods:

  • An observational, cross-sectional study was conducted at a children's hospice and a tertiary care hospital.
  • Anthropometric assessments and chart reviews (diagnosis, intake, medications) were performed on enterally fed, medically stable children.
  • Nutritional intakes were compared against established guidelines and recommendations.

Main Results:

  • Children's nutritional intakes were consistently below recommended levels.
  • All participants fell below the 50th percentile for weight-for-age, with many below the 3rd percentile.
  • Despite low weight, 14 out of 15 children showed higher percentiles for absolute and relative body fat.

Conclusions:

  • Recommended dietary intakes were not achieved by the study cohort.
  • Elevated body fat measures suggest that current intake may be adequate, despite low weight-for-age.
  • Standard growth charts, such as the Centers for Disease Control and Prevention (CDC) weight-for-age and body mass index, are not appropriate for assessing nutritional adequacy in this population.
  • Low weight may be attributed to diagnosis-related growth stunting, reduced muscle mass, or decreased bone density due to immobility.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
2.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
1.1K
Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
736